Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by duckdog68on Jun 19, 2018 11:50pm
291 Views
Post# 28196439

RE:Newbies pay close attention to Dr Pat.....

RE:Newbies pay close attention to Dr Pat.....So true.
Upon exercising 45 million warrants in Feb 2017, he remarked (empasis added):

"Our increased equity position in ProMetic represents a long term and strategic investment for us", said Dr. Patrick Soon-Shiong, Chief Executive Officer of California Capital Equity, LLC. "ProMetic has robust proprietary therapeutic platforms, promising growth potential and several plasma derived therapeutics expected to reach commercialization stages, starting in 2017 with plasminogen.  We, through other investment vehicles, also have an on-going partnership with ProMetic in relation to IVIG and anticipate further collaborations going forward", added Dr. Soon-Shiong”

As he says in the his keynote speech - be prepared to fight dogma.


foofadooo wrote: He has been a shareholder for years and this speech far outweighs anything the negative posters can squeeze out their wormy mouths. Any drug that threatens as many indications through the use of proteinomics, albumen and has very few side effects is about to upset the treatment of medical conditions through geonomics will be resisted by big pharma.....thanks to the internet and Dr Pat...we will burst one day....follow the $$$ listen to a few of his videos, proteomics is very important word get to understand it.......GLTA......   https://m.youtube.com/watch?v=HhRkSduDd3U


f
oof



Bullboard Posts